Bain Capital Life Sciences's book
17 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ | ▮ |
| Imperative Care | Surgical Devices | ▮ | ▮ | ▮ | ▮ |
| HeartFlow (NAS: HTFL) | Decision/Risk Analysis | ▮ | ▮ | ▮ | ▮ |
+ 14 more companies · all 17, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Bain Capital Life Sciences portfolio at a glance
17 portfolio companies are on record for Bain Capital Life Sciences, including Freenome, Imperative Care and HeartFlow (NAS: HTFL). The book leans Drug Discovery (4), Decision/Risk Analysis (2) and Biotech (1).
15 of the 17 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 17 recorded positions
- ·Watchlist + alerts for Bain Capital Life Sciences's activity